These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

780 related items for PubMed ID: 16771219

  • 1. A 24-year review on the epidemiology and control of measles in Singapore, 1981-2004.
    Ong G, Hoon HB, Ong A, Chua LT, Kai CS, Tai GK.
    Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):96-101. PubMed ID: 16771219
    [Abstract] [Full Text] [Related]

  • 2. Outbreak of measles in primary school students with high first dose MMR vaccination coverage.
    Ong G, Rasidah N, Wan S, Cutter J.
    Singapore Med J; 2007 Jul; 48(7):656-61. PubMed ID: 17609829
    [Abstract] [Full Text] [Related]

  • 3. Impact of a measles elimination strategy on measles incidence in Malaysia.
    Saraswathy TS, Zahrin HN, Norhashmimi H, Az-Ulhusna A, Zainah S, Rohani J.
    Southeast Asian J Trop Med Public Health; 2009 Jul; 40(4):742-7. PubMed ID: 19842408
    [Abstract] [Full Text] [Related]

  • 4. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH, Lee CY, Chih TW, Lee PI, Chang LY, Lin YJ, Hsu CM, Huang LM.
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [Abstract] [Full Text] [Related]

  • 5. The epidemiology of measles in England and Wales since the 1994 vaccination campaign.
    Gay N, Ramsay M, Cohen B, Hesketh L, Morgan-Capner P, Brown D, Miller E.
    Commun Dis Rep CDR Rev; 1997 Feb 07; 7(2):R17-21. PubMed ID: 9046124
    [Abstract] [Full Text] [Related]

  • 6. Measles epidemiology and elimination strategies in Turkey.
    Güriş D, Bayazit Y, Ozdemirer U, Buyurgan V, Yalniz C, Toprak I, Aycan S.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S230-4. PubMed ID: 12721918
    [Abstract] [Full Text] [Related]

  • 7. Humoral and cellular immune response after measles vaccination in Taiwan.
    Huang CL, Yang YH, Wang LC, Lin YT, Tsai YY, Chiang BL.
    J Microbiol Immunol Infect; 2005 Jun 15; 38(3):169-75. PubMed ID: 15986066
    [Abstract] [Full Text] [Related]

  • 8. Progress in measles and rubella elimination in Iran.
    Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F.
    Pediatr Infect Dis J; 2007 Dec 15; 26(12):1137-41. PubMed ID: 18043452
    [Abstract] [Full Text] [Related]

  • 9. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance.
    Pistol A, Hennessey K, Pitigoi D, Ion-Nedelcu N, Lupulescu E, Walls L, Bellini W, Strebel P.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S217-22. PubMed ID: 12721916
    [Abstract] [Full Text] [Related]

  • 10. Measles epidemiology and outbreak response immunization in a rural community in Peru.
    Sniadack DH, Moscoso B, Aguilar R, Heath J, Bellini W, Chiu MC.
    Bull World Health Organ; 1999 May 15; 77(7):545-52. PubMed ID: 10444877
    [Abstract] [Full Text] [Related]

  • 11. Accelerated measles control--Cambodia, 1999-2002.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2003 Jan 10; 52(1):4-6. PubMed ID: 12549899
    [Abstract] [Full Text] [Related]

  • 12. Measles epidemiology and its implications for a vaccination programme in Oman.
    Patel PK, Al-Awaidy ST, Bawikar S, Al-Busaidy S, Al-Mahrooqi S.
    East Mediterr Health J; 2008 Jan 10; 14(3):579-89. PubMed ID: 18720622
    [Abstract] [Full Text] [Related]

  • 13. [Surveillance of measles in Germany].
    Tischer A, Siedler A, Rasch G.
    Gesundheitswesen; 2001 Nov 10; 63(11):703-9. PubMed ID: 11713702
    [Abstract] [Full Text] [Related]

  • 14. Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.
    McIntyre P, Amin J, Gidding H, Hull B, Torvaldsen S, Tucker A, Turnbull F, Burgess M.
    Commun Dis Intell; 2000 Jun 10; Suppl():v-83. PubMed ID: 12049363
    [Abstract] [Full Text] [Related]

  • 15. Progress towards measles elimination in Singapore.
    Ho HJ, Low C, Ang LW, Cutter JL, Tay J, Chan KP, Ooi PL, Thoon KC, Goh KT.
    Vaccine; 2014 Dec 05; 32(51):6927-6933. PubMed ID: 25444818
    [Abstract] [Full Text] [Related]

  • 16. Progress toward measles elimination in Germany.
    Hellenbrand W, Siedler A, Tischer A, Meyer C, Reiter S, Rasch G, Teichmann D, Santibanez S, Altmann D, Claus H, Kramer M.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S208-16. PubMed ID: 12721915
    [Abstract] [Full Text] [Related]

  • 17. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS, Nokes DJ.
    Bull World Health Organ; 2001 May 15; 79(7):615-24. PubMed ID: 11477964
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of a measles vaccine efficacy during a measles outbreak in Mbare, City of Harare Zimbabwe.
    Mahomva AI, Moyo IM, Mbengeranwa LO.
    Cent Afr J Med; 1997 Sep 15; 43(9):254-6. PubMed ID: 9509644
    [Abstract] [Full Text] [Related]

  • 19. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
    Zhou F, Reef S, Massoudi M, Papania MJ, Yusuf HR, Bardenheier B, Zimmerman L, McCauley MM.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S131-45. PubMed ID: 15106102
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R, Rahman MM, Hassan Z, Hassan MS.
    Scand J Immunol; 2006 Dec 01; 64(6):684-9. PubMed ID: 17083626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.